[Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy?]
CONCLUSIONS: Despite doubts regarding the long-term safety of anti-VEGF therapy, it is the author's view that this is the only option to stabilise visual function. The impact of therapy-induced damage on the spontaneous progression of AMD and the biological status of the aging individual cannot be unequivocally assessed.
PMID: 27364637 [PubMed - as supplied by publisher]
Source: Der Ophthalmologe - Category: Opthalmology Authors: Garweg JG Tags: Ophthalmologe Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | Lucentis | Opthalmology | Ranibizumab Injection